Chemoinformaics analysis of Cinnamyl butyrate
| Molecular Weight | 204.269 | nRot | 5 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 8 |
| Exact Molecular Weight | 204.115 | nRing | 1 |
| Solubility: LogS | -3.547 | nHRing | 0 |
| Solubility: LogP | 3.141 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 33.9827 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.689 |
| Synth | 1.908 |
| Natural Product Likeliness | 0.491 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.158 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.539 |
| MDCK | 0.0000329 |
| BBB | 0.782 |
| PPB | 0.944469 |
| VDSS | 0.608 |
| FU | 0.0529377 |
| CYP1A2-inh | 0.994 |
| CYP1A2-sub | 0.577 |
| CYP2c19-inh | 0.939 |
| CYP2c19-sub | 0.291 |
| CYP2c9-inh | 0.548 |
| CYP2c9-sub | 0.893 |
| CYP2d6-inh | 0.152 |
| CYP2d6-sub | 0.541 |
| CYP3a4-inh | 0.199 |
| CYP3a4-sub | 0.307 |
| CL | 10.833 |
| T12 | 0.858 |
| hERG | 0.091 |
| Ames | 0.048 |
| ROA | 0.089 |
| SkinSen | 0.939 |
| Carcinogencity | 0.613 |
| EI | 0.978 |
| Respiratory | 0.118 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.582487 |